Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b study of PD 0299685 for vasomotor symptoms of menopause
2006-001322-25Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in menopause and hot flash comparing PD 0299685 with Placebo (2 arms). Primary endpoint: Change in frequency of moderate to severe vasomotor symptoms at Week 4. Started Jul 2006; status: completed.
02
Drugs
PD-0299685
03
Conditions
menopausehot flash
Beyond the preview
Go deeper on 2006-001322-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001322-25.